Identification of therapeutic vulnerabilities in ER+/RB1-deficient breast cancers
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210144
- Recipient
-
The University Of Texas Southwestern Medical Center UEI YZJ6DKPM4W63 Part of University Of Texas System
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $736,435
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Dallas, TX 75390, USA
Award details come from USAspending.gov.
About this award
The University of Texas Southwestern Medical Center received a three-year Project Grant award of $736,435 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research to identify therapeutic vulnerabilities in estrogen receptor-positive and RB1-deficient breast cancers through February 2025. The Military Medical Research and Development program supports innovative biomedical research with the goals of improving military and public health outcomes. This award advances those goals by exploring medical solutions for cancer treatment applicable both for service members and civilians.
Quick answers
Who received award W81XWH2210144?
W81XWH2210144 was awarded to The University Of Texas Southwestern Medical Center by Medical Command (Department of the Army) on March 1, 2022.
How much is award W81XWH2210144 worth?
$736,435 has been obligated on W81XWH2210144.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award